Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-08

Clinical Trial Update: Early Administration of Prothrombin Concentrate Complex in Patients With Acute Hemorrhage Following Severe Trauma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating early administration of Prothrombin Concentrate Complex in patients with acute hemorrhage after severe trauma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prothrombin Concentrate Complex (Prothrombin Complex Concentrate)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Shock, Hemorrhagic | Phase 3 | Status: COMPLETED